Transcend is well positioned for rapid expansion in important markets around the world.
MINNEAPOLIS (PRWEB) October 16, 2012
Somnetics International, Inc., the Minneapolis-based maker of Transcend® Sleep Apnea Therapy System™, announced that it has received approval to distribute its products in several key global markets including Australia, India, New Zealand, Columbia, Chile and Venezuela. Transcend received CE Mark in March 2012 expanding distribution in Europe and registration approval for expansion throughout Canada in October 2011.
Somnetics Senior Vice President of International Rischeh Kumarasinghe said, “Somnetics is well positioned for rapid expansion in important markets around the world. We have strong distributors that are ready to meet the demand that exists for Transcend in these markets.”
Transcend is changing the way sleep apnea therapy is delivered as the world’s smallest, lightest, most portable and flexible CPAP and battery system. Known as the industry leader in innovation, Transcend is also the first in the industry to bring proven Waterless Humidification™ technology and lightweight, long-life battery systems and solar power technology to CPAP users, making Transcend the preferred choice for travel and home use.
For information about Transcend and the industry’s most innovative CPAP products visit http://www.mytranscend.com or call 877-621-9626.
Transcend is the smallest, lightest and most portable CPAP and battery system available. The Transcend Sleep Apnea Therapy System offers options that make this the most flexible CPAP choice for travel and home use. Options include the lightweight, long-life P4 Overnight Battery System™ and the P8 Multi-Night Battery System™ to provide reliable power in remote locations and during power outages. Two Waterless Humidification™ system options harness innovative proprietary heat moisture exchange (HME) technology that eliminates the hassles of traditional heated humidifiers. Transcend is protected by several issued and pending US and foreign patents.
Somnetics International, Inc. is a privately-held medical device company based in Minneapolis, Minn. It is an emerging leader in customer-driven design, development and production of respiratory medical devices to treat sleep apnea and related issues. Somnetics’ mission is focused on integrating technology, customer input and employee creativity to provide innovative, high quality products that improve quality of life for people with respiratory disorders. Transcend received the 2011 Medtrade Innovation Award, the 2012 Medtrade Spring Provider’s Choice Award, and the 2012 Best Practices Award for Product Differentiation in the Sleep Disordered Breathing market from Frost & Sullivan. Somnetics received FDA market clearance for the Transcend CPAP machine in July 2010 and CE Mark in February 2012. Transcend and associated technology is protected by several issued and pending U.S. and foreign patents.
Media Contact: Kathleen Crandall 612/327-6336 (kathleen(at)crandallcommunications(dot)com)